Tautomycin (TTM), a potent protein phosphatase inhibitor, consists of a polyketide chain containing a spiroketal moiety and an acyl chain bearing a dialkylmaleic anhydride structure. PCR using degenerate primers was used to clone genes from Streptomyces spiroverticillatus for formation of the methoxymalonyl-acyl carrier protein. This locus was found to contain five genes (ttmC, ttmA, ttmD, ttmB, and ttmE), one of which was used as a probe to clone the 110-kb TTM biosynthetic gene cluster. The involvement of the ttmA gene in TTM biosynthesis was confirmed by gene inactivation and mutation complementation experiments.
Tautomycin (TTM) was first isolated from Streptomyces spiroverticillatus in 1987 (3), and its structure and relative and absolute stereochemistry were established on the basis of chemical degradation and spectroscopic evidence (5, 23, 24) . TTM consists of a polyketide chain containing a spiroketal moiety and an acyl chain bearing a dialkylmaleic anhydride unit (Fig. 1A) . The latter moiety under neutral conditions exists as two interconverting anhydride and diacid forms in approximately a 5:4 ratio (3, 5) , which is reflected in the name of this polyketide. TTM was originally found to exhibit potent antifungal activity and induce morphological change (bleb formation) in human leukemia cells (12) . Bleb formation was correlated with the inhibition of protein phosphatases (PPs), leading to the eventual finding that TTM is a potent inhibitor of both PP1 and PP2A with a 50% inhibitory concentration (IC 50 ) of 22 to 32 nM in weak preference to PP1 (11, 18, 22) . The closely related tautomycetin (TTN) (Fig. 1A) (4, 6) exhibits nearly 40-times-higher specificity for PP1 (IC 50 ϭ 1.6 nM) than PP2A (IC 50 ϭ 62 nM) (14, 18) . PP1 and PP2A are the catalytic subunits of two of the four major protein Ser/Thr phosphatase complexes that regulate diverse cellular events such as cell division, transcription, translation, muscle contraction, glycogen synthesis, and neuronal signaling in eukaryotic cells. Because of their ability to readily permeate cells, smallmolecule inhibitors of PPs have become useful tools for studying such intracellular events in vivo and represent leads to discover drugs for the treatment of several human diseases (8, 18, 19) .
Assembly of the right half of TTM and TTN from short carboxylic acid precursors can be readily envisaged according to the current type I polyketide synthase (PKS) paradigm with the TTM PKS featuring a methoxymalonyl-acyl carrier protein (ACP) extender unit and the TTN PKS featuring an ethylmalonyl coenzyme A (CoA) extender unit ( Fig. 1A) (25) . Here we report the amplification of putative ␤-hydroxyacyl-CoA dehydrogenase (HADH) and acyl-CoA dehydrogenase (ADH) genes from the TTM-producing S. spiroverticillatus strain by PCR, utilization of the resulting ADH fragment as a probe to clone the methoxymalonyl-ACP biosynthesis locus, and confirmation of the necessity of this locus for TTM biosynthesis by gene replacement and complementation experiments.
Cloning of putative HADH and ADH genes for methoxymalonyl-ACP biosynthesis from S. spiroverticillatus by PCR. Because it was inexpedient to attempt to identify the TTM gene cluster by correlation with the numerous ketosynthase loci cloned by PCR from S. spiroverticillatus using conventional primers (13, 15) (unpublished work), we turned to another cloning strategy. The biosynthetic gene clusters of PKSs that incorporate methoxymalonate as an extender unit have been cloned and characterized (10, 16, (26) (27) (28) (29) (30) (Fig. 1B) . Two highly conserved regions, VLGAGVMG and GRKSGRGF in HADH and QGMAAWTV and DAKLMEII in ADH, both of which are products of the known methoxymalonyl-ACP-specific genes (10, 16, (26) (27) (28) (29) (30) , were used to design primers FP1 (5Ј-GTC CTG GGC GCC GGS GTS ATG GG-3Ј) and RP1 (5Ј-GAA GCC GCG GCC SGA CTT SCG NCC-3Ј) for HADH and FP2 (5Ј-CAG GGC ATG GCC GCS TGG ACS GT-3Ј) and RP2 (5Ј-GAT GAT CTC CAT SAG CTT SGC RTC-3Ј) (N, G/A/T/C; R, A/G; S, C/G) for ADH by using the CODEHOP (consensus-degenerate hybrid primer) strategy (17) . Distinct products with the expected size (0.8 kb) were amplified by PCR from S. spiroverticillatus genomic DNA using typical conditions for high-GC-content genes (9) with both pairs and cloned into pGEM-T Easy (Promega, Madison, WI) to yield pBS6001 (for HADH) and pBS6002 (for ADH), respectively. Both plasmids were sequenced. While the PCRamplified HADH product exhibited lower homology to HADHs involved in methoxymalonyl-ACP biosynthesis, such as GdmK (28% identity) (16) and FkbK (27% identity) (27) identity] from Streptomyces avermitilis), the PCR-amplified ADH fragment (253 amino acids) was most similar to known ADHs for methoxymalonyl-ACP biosynthesis, such as GdmI (73% identity) (16) and FkbI (61% identity) (27) .
Cloning and sequencing of a methoxymalonyl-ACP biosynthesis locus from S. spiroverticillatus. An internal 0.55-kb ADH fragment was amplified from pBS6002 by PCR and used directly as a probe to screen the S. spiroverticillatus cosmid library prepared in SuperKos1 (a modified SuperCos1 [Stratagene, La Jolla, CA] that lacks the neomycin resistance marker) by standard methods (9, 20) . Of the 5,000 colonies screened by colony hybridization, 12 positive clones were identified and confirmed by PCR and Southern analysis. Restriction mapping and end sequencing revealed that these overlapping cosmids covered approximately 70 kb of DNA as exemplified by pBS6003, pBS6004, pBS6005, and pBS6006 (Fig. 2) . Chromosome walk- The 4.9-kb BamHI fragment that hybridized to the PCRamplified ADH probe was subcloned from pBS6004 as a BamHI restriction fragment into the same site of pBluescript II SK(ϩ) (Stratagene) to give pBS6008. DNA sequencing revealed five open reading frames, designated ttmA, ttmB, ttmC, ttmD, and ttmE (Fig. 2) . The ttmA gene, which contains the PCR-amplified ADH fragment, encodes an ADH that is highly homologous to GdmI (74% identity) (16), FkbI (63% identity) (27) , Asm15 (60% identity) (28), SorE (41% identity) (10, 30) , and OzmE (62% identity) (29), respectively. The ttmB gene encodes an HADH, distinct from one that was amplified from the genomic DNA by PCR, that shows high sequence homology to HADHs from known methoxymalonyl-ACP loci, such as GdmK (75% identity) (16), FkbK (59% identity) (27) , Asm13 (15% identity) (28), SorD (35% identity) (10, 30) , and OzmG (62% identity) (29) . The deduced gene products of ttmC, ttmD, and ttmE share high sequence homology to three other enzymes, an O-methyl transferase (TtmC), an ACP (TtmD), and a protein with no functional homologs that is proposed to play a role in glyceryl-ACP formation (TtmE), all of which are common in known methoxymalonyl-ACP biosynthesis loci (16, (26) (27) (28) (29) (30) .
Inactivation of ttmA by gene replacement and complementation of the ttmA::aac(3)IV mutation by ttmA expression. To confirm that the cloned methoxymalonyl-ACP locus is involved in TTM biosynthesis, ttmA was inactivated by gene replacement using REDIRECT Technology (7). The mutated cosmid, pBS6012, in which an internal 414-bp fragment of ttmA was replaced with the apramycin (Apr) resistance aac(3)IV/oriT gene cassette, was introduced into S. spiroverticillatus by conjugation using protocols for genetic manipulation of this organism (unpublished work). Exconjugants that were resistant to Apr (30 g/ml, International Streptomyces Project 4 [ISP-4] agar plates freshly supplemented with 10 mM MgCl 2 , incubated several days at 28°C) were selected as the desired double-crossover gene replacement mutants and named S. spiroverticillatus SB6001. Genomic DNAs from both the S. spiroverticillatus wild-type and SB6001 mutant strains were di- (Fig. 3A) , this fragment was shifted to 2.2 kb in the SB6001 mutant strain as would be predicted for the replacement of the internal 414-bp fragment of ttmA by the aac(3)IV/oriT cassette (Fig. 3B) .
To complement the ttmA::aac(3)IV mutation in the SB6001 strain, the ttmA expression construct pBS6009 was generated in the integrative plasmid pSET152 (1) by placing the ErmE* promoter in front of the ttmA gene to ensure efficient expression as follows. A 1.6-kb NcoI-PstI DNA fragment from pBS6008 containing the entire ttmA gene was treated with the Klenow DNA polymerase large fragment and ligated into the HincII site of pWHM79 that harbors the ErmE* promoter upstream (21) to yield pBS6010. Upon digestion with EcoRI and HindIII, the 2.0-kb ErmE*::ttmA fragment was isolated from pBS6010, blunt ended with the Klenow DNA polymerase large fragment, and ligated into the EcoRV site of pSET152 to yield pBS6011. Since SB6001 carries aac(3)IV, the 1.5-kb neomycin resistance gene (neo) was amplified from SuperCos1 and ligated into the EcoRI site of pBS6011 to furnish pBS6009 with an alternative marker for selection in SB6001. The latter was introduced into SB6001 by conjugation to yield Apr-resistant strain SB6002, in which pBS6009 is integrated into the S. spiroverticillatus chromosome via the C31 att site (1) and the expression of ttmA is under the control of the constitutive ErmE* promoter.
Characterization of TTM production in S. spiroverticillatus SB6001 and SB6002. Fermentations of S. spiroverticillatus SB6001 and SB6002 were carried out under identical conditions with the wild-type strain as a positive control. Optimized TTM production in the wild-type strain ranged from 10 to 15 mg/liter. The identity of the isolated TTM was confirmed by mass spectrometry analysis, yielding the characteristic molecular ions (m/e for [MϩH] ϩ ) of 767.1, consistent with the molecular formula of C 41 H 66 O 13 , and 1 H and 13 C nuclear magnetic resonance analyses, affording spectroscopic data that are identical to those reported in the literature (5). High-pressure liquid chromatography analysis of the fermentation cultures showed that inactivation of ttmA completely abolished TTM production in SB6001 and TTM production was partially restored (ϳ60% to that of the wild type) by expressing a functional copy of ttmA in trans (i.e., SB6002) (Fig. 3C) .
The hypothesis that the biosynthesis of methoxymalonyl-ACP starts from a glycolytic pathway intermediate (2, 26, 27) raises an interesting stereochemistry question. Since glycolytic pathway intermediates are known to have a D (i.e., 2R) configuration, a corollary of this hypothesis would be the prediction of (R)-methoxymalonyl-ACP as the sole extender unit for the biosynthesis of all methoxymalonate-containing polyketides, regardless of the stereochemistry of the final methoxymalonatederived unit in the natural products. The PKS modules that incorporate the (R)-methoxymalonyl-ACP unit must, therefore, control the stereochemistry of the methoxymalonate-derived units in the resultant natural products, as exemplified by the TTM PKS with the retention of configuration for TTM biosynthesis and the oxazolomycin PKS with the inversion of configuration for oxazolomycin biosynthesis (29) , respectively (Fig. 1) .
Nucleotide sequence accession number. The nucleotide sequence reported in this paper has been deposited in the GenBank database under accession number DQ088168.
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